News
-
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Merger Establishes US and EMEA Presence for the Preeminent Chinese Str
January 9, 20190 Comments -
Cerebral Embolic Protection Panel Discussion
Alexandra Lansky Patient Selection Device Selection Reimbursement and
December 3, 2018 -
The Importance of DW-MRI and Longitudinal Impact of Cerebral Ischemic Lesions
John Forrest Summary MRI lesions are very frequent after TAVR and are
December 3, 2018 -
TriGUARD3 Cerebral Embolic Protection Device Post-Market EU Registry Plan
Darius Dudek Financial Statement Study Design End-points Other Measure
December 3, 2018 -
TriGUARD3 Cerebral Embolic Protection Device Case Presentation
Early US Experience Michael Mack Prep Placement Deployment Delivery Va
December 3, 2018 -
REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device
Tamim Nazif Conclusions: TriGUARD 3 offers complete 3 vessel cerebral
December 3, 2018 -
Current Cerebral Embolic Protection Landscape
Keystone Heart TriGUARD Data Review Jeffrey Moses Conclusions: Overt a
December 3, 2018 -
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Merger Establishes US and EMEA Presence for the Preeminent Chinese Str
October 2, 2018 -
Join Keystone Heart at TCT2018
We invite you to explore and discuss with world-renown physicians the
September 13, 2018 -
-
What is Cerebral Reserve and Why Does It Matter?
What Is It? Cerebral reserve is the brain’s ability in the face of a
June 18, 2018 -
Why Care About Embolic Brain Lesions When We’re Talking About Cardiovascular Issues?
You may be wondering why it is important to discuss brain lesions in r
June 7, 2018